To extend our observations to another cancer model, we tested the effect of anti-PD-1 blocking antibodies in WT, TNF- and TNFR1-deficient mice injected with Lewis lung carcinoma (LLC) cells, which expressed MHC-I at low levels (Supplementary Fig. 3a). The gene discussed is TNFRSF1A; the disease is cancer.